# FDA Inspection 860747 - Nuspine Medical Technologies - December 30, 2013

Source: https://www.keypedia.com/records/fda_inspections/nuspine-medical-technologies/ee9b39a1-2de5-45f8-bca2-b9afe94a7a22
Source feed: FDA_Inspections

> FDA Inspection 860747 for Nuspine Medical Technologies on December 30, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 860747
- Company Name: Nuspine Medical Technologies
- Inspection Date: 2013-12-30
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 757248 - 2011-12-01](https://www.keypedia.com/records/fda_inspections/nuspine-medical-technologies/8f00ec45-aded-4854-a20b-08544acb2c4e)
- [FDA Inspection 647473 - 2010-02-22](https://www.keypedia.com/records/fda_inspections/nuspine-medical-technologies/842f4604-c610-4632-8e4d-62aef1a56d21)

Company: https://www.keypedia.com/companies/nuspine-medical-technologies/825af7cf-918f-49a4-af27-203f845a1a80

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d